-
11.发明申请Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis and methods of detecting FSAP and FSAP mutations 有权因子VII激活蛋白酶（FSAP）的Marburg I突变体作为动脉血栓形成的危险因素，以及检测FSAP和FSAP突变的方法公开(公告)号：US20070099229A1
公开(公告)日：2007-05-03
申请号：US11633501
申请日：2006-12-05
申请人： Stefan Kiechl , Johann Willeit , Christian Wiedermann , Juergen Roemisch , Thomas Weimer , Annette Feussner , Hans-Arnold Stoehr , Volker Doersam , Wiegand Lang , Margret Becker , Claudia Nerlich , Gudrun Muth-Naumann , Bernd Knoblauch
发明人： Stefan Kiechl , Johann Willeit , Christian Wiedermann , Juergen Roemisch , Thomas Weimer , Annette Feussner , Hans-Arnold Stoehr , Volker Doersam , Wiegand Lang , Margret Becker , Claudia Nerlich , Gudrun Muth-Naumann , Bernd Knoblauch
IPC分类号： C12Q1/68 , G01N33/567 , C12N9/64
CPC分类号： C12N9/6424 , C12N9/6421 , C12N9/647 , C12Q1/6883 , C12Q2600/112 , C12Q2600/156 , G01N33/6893 , G01N33/86 , G01N2800/323
摘要： A novel arterial thrombosis risk factor comprising one or more of the identified mutants of coagulation factor VII-activating protease (FSAP) is described. In addition, diagnostic determination methods for detecting these mutants which are identified as risk factors are described.
摘要翻译： 描述了包含一种或多种所鉴定的凝血因子VII活化蛋白酶（FSAP）的突变体的新型动脉血栓形成危险因素。 此外，描述了用于检测被鉴定为危险因素的这些突变体的诊断测定方法。
-
12.发明授权Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis 有权因子VII激活蛋白酶（FSAP）的Marburg I突变体作为动脉血栓形成的危险因素公开(公告)号：US07153679B2
公开(公告)日：2006-12-26
申请号：US10391215
申请日：2003-03-19
申请人： Stefan Kiechl , Johann Willeit , Christian Josef Wiedermann , Juergen Roemisch , Thomas Weimer , Annette Feussner , Hans-Arnold Stoehr , Volker Doersam , Wiegand Lang , Margret Becker , Claudia Nerlich , Gudrun Muth-Naumann , Bernd Knoblauch
发明人： Stefan Kiechl , Johann Willeit , Christian Josef Wiedermann , Juergen Roemisch , Thomas Weimer , Annette Feussner , Hans-Arnold Stoehr , Volker Doersam , Wiegand Lang , Margret Becker , Claudia Nerlich , Gudrun Muth-Naumann , Bernd Knoblauch
CPC分类号： C12N9/6424 , C12N9/6421 , C12N9/647 , C12Q1/6883 , C12Q2600/112 , C12Q2600/156 , G01N33/6893 , G01N33/86 , G01N2800/323
摘要： A novel arterial thrombosis risk factor comprising one or more of the identified mutants of coagulation factor VII-activating protease (FSAP) is described. In addition, diagnostic determination methods for detecting these mutants which are identified as risk factors are described.
摘要翻译： 描述了包含一种或多种所鉴定的凝血因子VII活化蛋白酶（FSAP）的突变体的新型动脉血栓形成危险因素。 此外，描述了用于检测被鉴定为危险因素的这些突变体的诊断测定方法。
-
13.发明申请Mutants of the factor VII-activating protease and detection methods using specific antibodies 有权因子VII活化蛋白酶的突变体和使用特异性抗体的检测方法公开(公告)号：US20050032109A1
公开(公告)日：2005-02-10
申请号：US10930754
申请日：2004-09-01
申请人： Juergen Roemisch , Hans-Arnold Stoehr , Annette Feussner , Wiegand Lang , Thomas Weimer , Margret Becker , Claudia Nerlich , Gudrun Muth-Naumann , Bernd Knoblauch
发明人： Juergen Roemisch , Hans-Arnold Stoehr , Annette Feussner , Wiegand Lang , Thomas Weimer , Margret Becker , Claudia Nerlich , Gudrun Muth-Naumann , Bernd Knoblauch
IPC分类号： G01N33/53 , C07K16/40 , C12N9/50 , C12N9/64 , C12N15/09 , C12N15/57 , C12P21/08 , C12Q1/56 , C12Q1/68 , G01N33/533 , G01N33/534 , G01N33/535 , C07H21/04 , C07K14/755 , C12P21/04
CPC分类号： C12N9/647 , A61K38/00 , C07K16/40 , C12N9/6424 , G01N33/86 , G01N2333/96463
摘要： Mutants of the DNA sequence coding for the protease (FSAP) which activates blood clotting factor VII and single-chain plasminogen activators, the mutant comprising a G/C base exchange at nucleotide position 1177 and/or a G/A base exchange at nucleotide position 1601, is described. The corresponding protease has a Glu/Gln exchange at amino acid position 393 and/or a Gly/Glu exchange at amino acid position 534. Furthermore, diagnostic methods which are used for detecting FSAP in body fluids or tissue cells and also for identifying patients with genetic heterozygous or homozygous FSAP expression are described. In addition, antibodies against FSAP and its mutants are disclosed and diagnostic methods which can be used to detect antibodies against FSAP and its mutants are specified.
摘要翻译： 编码激活血液凝固因子VII和单链纤溶酶原激活物的蛋白酶（FSAP）的DNA序列的突变体，其在核苷酸位置1177处包含G / C碱基交换和/或在核苷酸位置处的G / A碱基交换 1601。 相应的蛋白酶在氨基酸位置393处具有Glu / Gln交换和/或氨基酸位置534处的Gly / Glu交换。此外，用于检测体液或组织细胞中的FSAP的诊断方法以及用于鉴定患有 描述了遗传杂合或纯合FSAP表达。 另外，公开了针对FSAP及其突变体的抗体，并且可以用于检测针对FSAP及其突变体的抗体的诊断方法。
-
公开(公告)号：US06737405B2
公开(公告)日：2004-05-18
申请号：US09849343
申请日：2001-05-07
IPC分类号： A61K3800
CPC分类号： A61K47/183 , A61K38/57 , A61K47/26
摘要： A stabilized protein preparation is described which contains no antithrombin III and is protected against loss of activity during pasteurization by the addition of stabilizers which comprise one or more saccharides as a mixture with more than 0.5 mol/l of one or more amino acids chosen from the group arginine, lysine, histidine, phenylalanine, tryptophan, tyrosine, aspartic acid and its salts or glutamic acid and its salts. Glycine and/or glutamine can also be additionally added to each of these amino acids. A process for the viral inactivation or viral depletion of a protein preparation of this type which contains the abovementioned stabilizers and is subjected to pasteurization or viral depletion by filtration, centrifugation or treatment with detergents or bactericidal or virucidal agents is also described.
-
-
-
搜索结果
14 条记录 (耗时 0.02 秒)
